Chemical Formula: C23H20N2O5
Chemical Formula C23H20N2O5
Found 7 metabolite its formula value is C23H20N2O5
Bentiromide
Bentiromide is a peptide used as a screening test for exocrine pancreatic insufficiency and to monitor the adequacy of supplemental pancreatic therapy. It is given by mouth as a noninvasive test. The amount of 4-aminobenzoic acid and its metabolites excreted in the urine is taken as a measure of the chymotrypsin-secreting activity of the pancreas. Headache and gastrointestinal disturbances have been reported in patients taking bentiromide. Bentiromide is not available in the U.S. or Canada (It was withdrawn in the US in October 1996). V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CK - Tests for pancreatic function D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. The bentiromide test is an excellent means of confirming the diagnosis of pancreatic exocrine insufficiency by outpatient test of chymotrypsin function[1].
1,3-Benzodioxolane-5-carboxylicacid4'-benzyloxy-3'-methoxybenzylidenehydrazide
Bentiromide
V - Various > V04 - Diagnostic agents > V04C - Other diagnostic agents > V04CK - Tests for pancreatic function D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents Bentiromide is a peptide that is broken down in the pancreas by chymotrypsin. The bentiromide test is an excellent means of confirming the diagnosis of pancreatic exocrine insufficiency by outpatient test of chymotrypsin function[1].
1,3-Benzodioxolane-5-carboxylic acid 4-benzyloxy-3-methoxybenzylidene hydrazide
N-Benzoyl-L-tyrosyl-p-aminobenzoic acid
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents